Form D · Pharmaceuticals
Fiorello Pharmaceuticals, Inc.
New York, NY · CIK 0001642510
Offering snapshot reported Jun 17, 2015 · SEC filing
- Reported sold
- $2.55M Offering amount: $2.55M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 4, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2015 | Initial | $2,549,916 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $204K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-241956
?Total Amount Sold? means cash and binding commitments to purchase stock; excludes $5MM of add?l expected subscriptions payable when NY State Dept of Health grants a business license to issuer. Post-license, expected total amount sold will be $7,549,916.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| CASTLEOAK SECURITIES, LP | 125334 |
Source: Form D, filed Jun 17, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aaron Hoffnung | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
205 East 42 Nd Street, 15 Th Floor
New York, NY, 10017
New York, NY, 10017